Hypotheses: melatonin/steroid combination contraceptives will prevent breast cancer
- PMID: 7749153
- DOI: 10.1007/BF00665950
Hypotheses: melatonin/steroid combination contraceptives will prevent breast cancer
Abstract
The use of the conventional combination oral contraceptives (containing ethinyl-estradiol and a progestin) is associated with reduced risk of ovarian and endometrial cancer. However, prolonged use of these pills before first term pregnancy apparently increases the risk of pre menopausal breast cancer. We propose that the pineal gland hormone melatonin, combined with a progestin, as a new and novel oral contraceptive combination might prevent breast cancer in long term users. This hypothesis is based on the assumption that women have a propensity to develop breast cancer which correlates with number of ovulatory cycles over their lifetime. In evolution, the phylogenetic point at which women became sensitive to breast cancer evolved at a transfer point of the mechanism of ovulation from seasonal ovulation, which is still common in many mammalian species, to the current human pattern of continuous ovulatory cycles. We suggest that melatonin/ovarian-steroid contraceptive will restore the lost mechanism of endogenous anovulation, and thus, by preventing continuous epithelial breast cell proliferation, will reduce the risk of breast cancer in long-term users.
Similar articles
-
The prevention of breast cancer through reduced ovarian steroid exposure.Acta Oncol. 1992;31(2):167-74. doi: 10.3109/02841869209088898. Acta Oncol. 1992. PMID: 1622631 Review.
-
A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.Contraception. 1997 Jul;56(1):23-30. doi: 10.1016/s0010-7824(97)00070-x. Contraception. 1997. PMID: 9306028 Clinical Trial.
-
A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.Contraception. 1998 Jan;57(1):39-44. doi: 10.1016/s0010-7824(97)00205-9. Contraception. 1998. PMID: 9554249 Clinical Trial.
-
Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.Am J Obstet Gynecol. 1998 Jul;179(1):41-6. doi: 10.1016/s0002-9378(98)70249-2. Am J Obstet Gynecol. 1998. PMID: 9704763 Clinical Trial.
-
Exogenous progestins and breast cancer.Epidemiol Rev. 1993;15(1):98-107. doi: 10.1093/oxfordjournals.epirev.a036120. Epidemiol Rev. 1993. PMID: 8405216 Review.
Cited by
-
Melatonin: Countering Chaotic Time Cues.Front Endocrinol (Lausanne). 2019 Jul 16;10:391. doi: 10.3389/fendo.2019.00391. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31379733 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical